July 6, 2009
CTI Clinical Trial and Consulting Services (CTI) received the prestigious Oracle Health Sciences Award for “Accelerating Interests for Better Health” at a reception during the Drug Information Association Annual Meeting that took place last week in San Diego, California. The award was presented by Neil de Crescenzo, Senior Vice President and General Manager, Oracle Health Sciences Global Business Unit.
“Oracle Clinical works with the largest pharmaceutical companies and contract research organizations and we are honored to be singled out for our work with them from among our peers in the industry,” said Timothy J Schroeder, President and CEO of CTI Clinical Trial and Consulting Services. “The partnership of CTI and Oracle is a compelling example of how life science organizations can innovate to achieve great outcomes.”
CTI was awarded in part for their continuing collaboration with Oracle Health Sciences Global Business Unit throughout the years. In January of 2009, CTI announced their expanded use of Oracle applications for clinical development and recently upgraded to the newest releases of Oracle® Clinical, Oracle Adverse Event Reporting System and Oracle Remote Data Capture 4.5.3.
“We invested in Oracle’s clinical applications suite from the very start of our organization because it is a leader that has the confidence of the biotech and pharmaceutical industry. Over the years, Oracle has been very flexible and eager to work with our emerging organization, playing an important supporting role in continued growth, and we are very happy to be honored by them with this award” said Kevin Schwarz, Senior Vice President, Clinical Trial Operations.